Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY.
Clin Spine Surg. 2023 Nov 1;36(9):356-362. doi: 10.1097/BSD.0000000000001528. Epub 2023 Sep 8.
Systemic review.
To understand the role of cervical disk arthroplasty in the treatment of cervical myelopathy.
The surgical management of degenerative cervical myelopathy (DCM) most frequently involves decompression and fusion, but stiffness introduced by the fusion and adjacent segment degeneration remain problems that can result in significant morbidity. Cervical disk arthroplasty (CDA) is a newer procedure that has been demonstrated to be safe and effective for the management of cervical spine degenerative disk disease, but it has not been traditionally considered as a treatment option for DCM and the use for this indication has not been extensively studied.
A systematic review was undertaken using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines using a search strategy to query all relevant articles on the use of cervical disk arthroplasty in the setting of cervical myelopathy over a 20-year period (2004-2023). This review examines the literature to assess our current understanding of the appropriateness, safety, and value of CDA in the treatment of DCM.
A total of 844 patients received CDA across the 14 studies that met inclusion criteria, with an average of 60.3±40.4 patients per study (range: 11-152 subjects). Featured studies included 5 (35.7%) prospective studies, of which 2 were randomized. All studies had primary outcome measures of disability and/or pain scores, with the Japanese Orthopedic Association myelopathy score and neck disability index as the most commonly assessed. Four (26.7%) studies compared arthroplasty with arthrodesis. Safety of CDA for DCM was found in all studies with improvement in clinical outcome measurements.
Cervical disk arthroplasty appears to be a safe and effective surgical option in the management of degenerative cervical myelopathy. Further study is needed to assess if arthroplasty provides clinical improvement in DCM of comparable magnitude and durability as traditional fusion strategies.
系统评价。
了解颈椎间盘置换术在治疗颈椎病中的作用。
退行性颈椎病(DCM)的手术治疗最常涉及减压和融合,但融合和相邻节段退变引起的僵硬仍然是导致显著发病率的问题。颈椎间盘置换术(CDA)是一种较新的手术方法,已被证明对治疗颈椎退行性椎间盘疾病安全有效,但传统上并未将其视为 DCM 的治疗选择,并且该适应症的应用尚未得到广泛研究。
采用系统评价首选报告项目和荟萃分析指南,使用检索策略查询 20 年来(2004-2023 年)关于颈椎间盘置换术在颈椎病治疗中的应用的所有相关文章。本综述评估文献,以评估我们对 CDA 在 DCM 治疗中的适宜性、安全性和价值的现有认识。
在符合纳入标准的 14 项研究中,共有 844 例患者接受了 CDA,每项研究的平均患者数为 60.3±40.4(范围:11-152 例)。特色研究包括 5 项(35.7%)前瞻性研究,其中 2 项为随机研究。所有研究均以残疾和/或疼痛评分作为主要终点测量指标,日本矫形协会脊髓病评分和颈部残疾指数是最常用的评估指标。4 项(26.7%)研究比较了关节成形术与关节融合术。所有研究均发现 CDA 治疗 DCM 的安全性良好,临床结局测量指标均有改善。
颈椎间盘置换术似乎是治疗退行性颈椎病的一种安全有效的手术选择。需要进一步研究评估关节置换术是否能提供与传统融合策略相当的临床改善效果和耐久性。